blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3972589

EP3972589 - NATRIURETIC PEPTIDE RECEPTOR A AGONISTS USEFUL FOR THE TREATMENT OF CARDIOMETABOLIC DISEASES, KIDNEY DISEASE AND DIABETES [Right-click to bookmark this link]
StatusThe patent has been granted
Status updated on  31.05.2024
Database last updated on 03.09.2024
FormerGrant of patent is intended
Status updated on  07.02.2024
FormerRequest for examination was made
Status updated on  25.02.2022
FormerThe international publication has been made
Status updated on  27.11.2020
Most recent event   Tooltip31.05.2024(Expected) grantpublished on 03.07.2024  [2024/27]
Applicant(s)For all designated states
Merck Sharp & Dohme LLC
126 East Lincoln Avenue
Rahway, New Jersey 07065 / US
[2022/42]
Former [2022/13]For all designated states
Merck Sharp & Dohme Corp.
126 East Lincoln Road
Rahway, New Jersey 07065-0907 / US
Inventor(s)01 / BENNETT, Frank
2000 Galloping Hill Road
Kenilworth, New Jersey 07033 / US
02 / IMBRIGLIO, Jason, E.
2000 Galloping Hill Road
Kenilworth, New Jersey 07033 / US
03 / KEREKES, Angela, D.
2000 Galloping Hill Road
Kenilworth, New Jersey 07033 / US
04 / KHAN, Tanweer
21 Forest Avenue
Bridgewater, New Jersey 08807 / US
05 / LANKIN, Claire
2000 Galloping Hill Road
Kenilworth, New Jersey 07033 / US
06 / LI, Derun
33 Avenue Louis Pasteur
Boston, Massachusetts 02115-5727 / US
07 / WU, Zhicai
2000 Galloping Hill Road
Kenilworth, New Jersey 07033 / US
08 / XIONG, Yusheng
60 Bradford Lane
Plainsboro, New Jersey 08536 / US
09 / YOUM, Hyewon
2000 Galloping Hill Road
Kenilworth, New Jersey 07033 / US
10 / YU, Yang
2000 Galloping Hill Road
Kenilworth, New Jersey 07033 / US
11 / KURISSERY, Anthappan Tony
Flat F3-802, SNN RAJ Greenbay Apartments 1st Main
Road Near Tech Mahindra Electronic City Phase II
Bangalore 560100 / IN
12 / KOMANDURI, Venukrishnan
21 Egerton Court Upper Park Road
Manchester M14 5SL / GB
13 / YE, Feng
deceased / US
 [2022/13]
Representative(s)Merck Sharp & Dohme LLC
120 Moorgate
London EC2M 6UR / GB
[2024/27]
Former [2022/13]Jaap, David Robert
Merck Sharp & Dohme Corp.
120 Moorgate
London, EC2M 6UR / GB
Application number, filing date20808662.918.05.2020
[2022/13]
WO2020US33356
Priority number, dateUS201962851534P22.05.2019         Original published format: US 201962851534 P
[2022/13]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2020236690
Date:26.11.2020
Language:EN
[2020/48]
Type: A1 Application with search report 
No.:EP3972589
Date:30.03.2022
Language:EN
The application published by WIPO in one of the EPO official languages on 26.11.2020 takes the place of the publication of the European patent application.
[2022/13]
Type: B1 Patent specification 
No.:EP3972589
Date:03.07.2024
Language:EN
[2024/27]
Search report(s)International search report - published on:US26.11.2020
(Supplementary) European search report - dispatched on:EP23.03.2023
ClassificationIPC:A61P13/12, A61P3/10, C07D401/12, C07D401/14, C07D413/14, C07D487/10, C07D491/107, C07D498/08, A61K31/435
[2023/17]
CPC:
A61P3/10 (EP); C07D491/107 (EP,US); A61K45/06 (US);
A61P13/12 (EP); C07D401/12 (EP); C07D401/14 (EP,US);
C07D413/14 (EP,US); C07D487/10 (EP); C07D498/08 (EP) (-)
C-Set:
A61K31/473, A61K2300/00 (EP);
A61K31/501, A61K2300/00 (EP);
A61K31/5377, A61K2300/00 (EP)
Former IPC [2022/13]A61K31/41, A61K31/415, A61K31/155
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/13]
Extension statesBANot yet paid
MENot yet paid
Validation statesKHNot yet paid
MANot yet paid
MDNot yet paid
TNNot yet paid
TitleGerman:NATRIURETISCHE PEPTID-REZEPTOR-A-AGONISTEN ZUR BEHANDLUNG VON KARDIOMETABOLISCHEN ERKRANKUNGEN, NIERENERKRANKUNGEN UND DIABETES[2022/13]
English:NATRIURETIC PEPTIDE RECEPTOR A AGONISTS USEFUL FOR THE TREATMENT OF CARDIOMETABOLIC DISEASES, KIDNEY DISEASE AND DIABETES[2022/13]
French:AGONISTES DU RÉCEPTEUR DU PEPTIDE NATRIURÉTIQUE A UTILES POUR LE TRAITEMENT DE MALADIES CARDIOMÉTABOLIQUES, DE MALADIES RÉNALES ET DU DIABÈTE[2022/13]
Entry into regional phase22.12.2021National basic fee paid 
22.12.2021Search fee paid 
22.12.2021Designation fee(s) paid 
22.12.2021Examination fee paid 
Examination procedure22.12.2021Examination requested  [2022/13]
04.10.2023Amendment by applicant (claims and/or description)
08.02.2024Communication of intention to grant the patent
24.05.2024Fee for grant paid
24.05.2024Fee for publishing/printing paid
24.05.2024Receipt of the translation of the claim(s)
Fees paidRenewal fee
21.03.2022Renewal fee patent year 03
21.03.2023Renewal fee patent year 04
18.03.2024Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]WO2018175534  (PHARMAIN CORP [US]);
 [E]WO2020236688  (MERCK SHARP & DOHME [US], et al)
International search[A]WO2018057618  (DANA FARBER CANCER INST INC [US], et al);
 [A]WO2018098473  (DANA FARBER CANCER INST INC [US], et al);
by applicantUS4845079
 US4885292
 US4894437
 US4980283
 US5034512
 US5036054
 US5036053
 US5055466
 US5063208
 US5063207
 US5064965
 US5066643
 US5071837
 US5075451
 US5089471
 US5095119
 US5098924
 US5104869
 US5106835
 US5114937
 US5116835
 WO9728149
 WO0208188
 WO2004020408
 WO2004020409
 WO2010039789
 WO2018175534
 WO2020236688
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.